GLOBALT Investments LLC GA Raises Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GLOBALT Investments LLC GA lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% in the 4th quarter, Holdings Channel reports. The firm owned 6,893 shares of the medical equipment provider’s stock after acquiring an additional 84 shares during the period. GLOBALT Investments LLC GA’s holdings in Intuitive Surgical were worth $3,598,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Atala Financial Inc purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $25,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth approximately $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical in the fourth quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth approximately $31,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the third quarter worth approximately $33,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Evercore ISI upped their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Leerink Partners increased their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, Bernstein Bank raised their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $613.10.

Insider Buying and Selling

In related news, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $484.44 on Monday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business has a fifty day moving average price of $567.46 and a 200-day moving average price of $531.94. The company has a market capitalization of $172.55 billion, a PE ratio of 75.58, a PEG ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.